Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2019

Hospital revisits within 30 days after discharge for medical
conditions targeted by the Hospital Readmissions Reduction
Program in the United States: National retrospective analysis
Rishi K. Wadhera
Harvard University

Karen E. Joynt Maddox
Washington University School of Medicine in St. Louis

Dhruv S. Kazi
Harvard University

Changyu Shen
Harvard University

Robert W. Yeh
Harvard University

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Wadhera, Rishi K.; Joynt Maddox, Karen E.; Kazi, Dhruv S.; Shen, Changyu; and Yeh, Robert W., ,"Hospital
revisits within 30 days after discharge for medical conditions targeted by the Hospital Readmissions
Reduction Program in the United States: National retrospective analysis." BMJ. 366,. . (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8077

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Hospital revisits within 30 days after discharge for medical
conditions targeted by the Hospital Readmissions Reduction
Program in the United States: national retrospective analysis
Rishi K Wadhera,1 Karen E Joynt Maddox,2 Dhruv S Kazi,1 Changyu Shen,1 Robert W Yeh1
1
Richard A and Susan F
Smith Center for Outcomes
Research in Cardiology, Division
of Cardiology, Beth Israel
Deaconess Medical and Harvard
Medical School, 185 Pilgrim
Road, Boston, MA 02215, USA
2
Department of Medicine,
Cardiovascular Division,
Washington University School of
Medicine, St Louis, MO, USA
Correspondence to:
R K Wadhera
rwadhera@bidmc.harvard.edu
(or @rkwadhera on Twitter;
ORCID 0000-0003-1089-3896)
Additional material is published
online only. To view please visit
the journal online.

Cite this as: BMJ 2019;366:l4563
http://dx.doi.org/10.1136/bmj.l4563

Accepted: 20 June 2019

Abstract
Objective
To determine any changes in total hospital revisits
within 30 days of discharge after a hospital stay
for medical conditions targeted by the Hospital
Readmissions Reduction Program (HRRP).
Design
Retrospective cohort study.
Setting
Hospital stays among Medicare patients for heart
failure, acute myocardial infarction, or pneumonia
between 1 January 2012 and 1 October 2015.
Participants
Medicare fee-for-service patients aged 65 or over.
Main outcomes
Total hospital revisits within 30 days of discharge
after hospital stays for medical conditions targeted by
the HRRP, and by type of revisit: treat-and-discharge
visit to an emergency department, observation stay
(not leading to inpatient readmission), and inpatient
readmission. Patient subgroups (age, sex, race) were
also evaluated for each type of revisit.

What is already known on this topic
Readmission rates at 30 days are increasingly used to measure quality of care
and evaluate provider and hospital performance under value based payment
programs in the United States
Readmission rates for medical conditions targeted by one such program, the
Hospital Readmissions Reduction Program (heart failure, acute myocardial
infarction, and pneumonia), have declined modestly on a national scale
Policymakers have attributed these reductions to improved discharge planning,
care transitions, and post-discharge care after index hospital stays, but these
declines could be because clinicians and hospitals have increasingly adopted
strategies to manage patients who return to a hospital within 30 days of
discharge in emergency departments or as observation stays—which are not
included in the current readmission measure

What this study adds
Total hospital revisits within 30 days of discharge after a hospital admission for
target conditions have steadily increased under the HRRP, due to a rise in treatand-discharge visits in an emergency department and observation stays
Although reductions in readmissions have been attributed to improvements
in discharge planning and transitional care, as intended by the HRRP, these
declines instead appear to be due to intensified efforts to manage patients who
return within 30 days of discharge in emergency departments and observation
units
A metric to measure patients’ 30 day return to hospital that captures all postdischarge encounters (inpatient, emergency department, and observation stays)
could provide a more comprehensive, accurate, and fair assessment of hospital
quality and performance
the bmj | BMJ 2019;366:l4563 | doi: 10.1136/bmj.l4563

Results
Our study cohort included 3 038 740 total index
hospital stays from January 2012 to September
2015: 1 357 620 for heart failure, 634 795 for acute
myocardial infarction, and 1 046 325 for pneumonia.
Counting all revisits after discharge, the total number
of hospital revisits per 100 patient discharges for
target conditions increased across the study period
(monthly increase 0.023 visits per 100 patient
discharges (95% confidence interval 0.010 to 0.035)).
This change was due to monthly increases in treatand-discharge visits to an emergency department
(0.023 (0.015 to 0.032) and observation stays (0.022
(0.020 to 0.025)), which were only partly offset
by declines in readmissions (−0.023 (−0.035 to
−0.012)). Increases in observation stay use were more
pronounced among non-white patients than white
patients. No significant change was seen in mortality
within 30 days of discharge for target conditions
(−0.0034 (−0.012 to 0.0054)).
Conclusions
In the United States, total hospital revisits within 30
days of discharge for conditions targeted by the HRRP
increased across the study period. This increase was
due to a rise in post-discharge emergency department
visits and observation stays, which exceeded the
decline in readmissions. Although reductions in
readmissions have been attributed to improvements
in discharge planning and care transitions, our
findings suggest that these declines could instead
be because hospitals and clinicians have intensified
efforts to treat patients who return to a hospital within
30 days of discharge in emergency departments and
as observation stays.

Introduction
Healthcare systems around the world are intensifying
efforts to deliver higher value care. Reducing
preventable hospital visits has drawn policy attention
as an opportunity to improve quality of care and
reduce healthcare spending in several countries,
including the United States, England, Denmark, and
Germany.1 In the US, the Centers for Medicare and
Medicaid Services (CMS) has implemented national
initiatives that aim to push clinicians and hospitals
to reduce readmissions for Medicare fee-for-service
patients over the age of 65. In 2009, for example, CMS
began publicly reporting 30 day readmission rates as
a measure of hospital performance. One year later, the
Hospital Readmissions Reduction Program (HRRP)
was established, mandating that CMS impose financial
penalties on acute care hospitals in the US with higher
than expected 30 day readmission rates after a hospital
1
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stay for common medical conditions. Penalties under
the HRRP began in 2012 and are capped at 3% of
Medicare payments to hospitals; 82% of hospitals
were penalized in fiscal year 2019.2
Readmissions alone, however, do not capture the
full spectrum of hospital revisits that can occur after
discharge. A return visit to an emergency department,
even if it does not result in an inpatient hospital
stay, might also reflect inadequate care transitions
or fragmented post-discharge care. In addition,
observation stays, which are short hospital stays that
are reimbursed differently from full inpatient hospital
stays, are increasingly being used in the US as an
alternative to inpatient hospital stays, and can occur
in an emergency department, hospital observation
unit, or a typical inpatient ward setting.3 However,
neither of these encounters (emergency department
or observation stays) are included as outcomes in the
30 day readmission measure used by CMS to evaluate
hospital care quality under the HRRP.4
Understanding nationwide trends in total hospital
based encounters (including treat-and-discharge visits
to an emergency department, observation stays, or
inpatient readmissions) within 30 days of discharge,
for conditions targeted by the HRRP, is critically
important from a policy perspective. A reduction in
total revisits would suggest widespread improvements
in discharge planning and transitions of care during
hospital stays, as well as care coordination and quality
in the post-discharge period, as intended by the HRRP.
By contrast, if hospital revisits after discharge have
not changed, or have increased, previously observed
reductions in readmissions5 might simply reflect greater
management of patients in emergency departments
and observation units, and the readmission measure
currently used by CMS could provide an incomplete
picture of hospital performance. Therefore, in this
study, we aimed to answer three policy relevant
questions:
•

•

•

Have total hospital revisits within 30 days of
discharge after a hospital stay for medical conditions
targeted by the HRRP changed over time?
How have rates of treat-and-discharge visits to an
emergency department, observation stays (not
leading to readmission), and readmissions each
contributed to changes in total hospital revisits?
Do these patterns differ if all 30 day post-discharge
revisits per patient are counted, to provide a more
comprehensive assessment of hospital use after
discharge, rather than just the first revisit as done
by CMS for the readmission measure?

Methods
Study cohort
We used Medicare Provider Analysis and Review files
to identify index hospital stays at acute care hospitals
from 1 January 2012 to 1 October 2015 with a principal
discharge diagnosis of heart failure, acute myocardial
infarction, or pneumonia—medical conditions targeted
by the HRRP. We defined study cohorts using ICD-9-CM
2

(international classification of diseases, 9th revision,
clinical modification) codes used in the publicly
reported CMS readmission and mortality measures.
We included Medicare beneficiaries aged 65 or older
who were alive at discharge, and excluded patients
who were discharged against medical advice, were
not enrolled in Medicare fee for service for at least 30
days after discharge (absent death), or were enrolled
in Medicare fee for service for less than one year before
hospital admission. Transfers to other hospitals were
linked to one index hospital stay.6 Comorbidities were
defined by hierarchical condition categories based
on inpatient Medicare claims up to one year before
hospital admission, and diagnosis codes per claim
were limited to the first nine codes,7 as has been done
in previous studies.5 6 8 9 We used outpatient claims
files and previously described methods to identify
observation stays10 as well as treat-and-discharge
visits to an emergency department3 that occurred
within 30 days of discharge after the index hospital
stay.

Outcomes
Our primary outcome was the trend in total hospital
revisits within 30 days of discharge after a hospital stay
for medical conditions targeted by the HRRP. We also
evaluated revisits by type: treat-and-discharge visits to
an emergency department, observation stays (not later
leading to readmission), and readmissions. For each
revisit, we used two different approaches: we counted
only one revisit (the first event after discharge) for each
type of encounter after the index hospital stay, as CMS
does for the readmission measure4; and we counted all
revisits within 30 days of discharge.
Statistical analysis
Logistic regression was used to fit a model for the
outcome of the first post-discharge revisit among
patients surviving up to discharge. We used a Poisson
regression model for the outcome of all revisits.
Models included reason for the index hospital stay
(eg, heart failure, acute myocardial infarction, or
pneumonia), demographics (age, sex, race), and
clinical comorbidities as independent variables. After
constructing separate models for each month (45
models for 45 months), we estimated the mean of the
potential outcomes for each respective month using
the demographics and clinical comorbidity profiles of
patients admitted to hospital in 2014 as a reference,
which was the most recent year that contained 12
calendar months of data. A smoothing spline was then
fitted to the 45 data points to show temporal trends.
A simple linear regression was also fitted to the 45
data points to estimate the monthly change for each
type of revisit per 100 patient discharges. We then
repeated this analysis to evaluate trends in revisits by
patient subgroups. Additional details regarding the
methodological approach and inferential strategy are
provided in the supplement. Analyses were performed
with SAS version 9.4 (SAS Institute). Institutional
review board approval, including waiver of the
doi: 10.1136/bmj.l4563 | BMJ 2019;366:l4563 | the bmj
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requirement of participant informed consent because
the data were deidentified, was provided by the Beth
Israel Deaconess Medical Center.

Patient and public involvement
Patients and the public were not involved in planning,
design, or interpretation of the study. The study
involved examination of existing claims data and
no participants were recruited for this analysis. We
intend to engage patients and health policymakers by
disseminating this research through press releases,
blog posts, and at research meetings. This research
was done without patient involvement. Patients were
not invited to comment on the study design and were
not consulted to develop patient relevant outcomes
or interpret the results. Patients were not invited to
contribute to the writing or editing of this document
for readability or accuracy.
Results
Our study cohort included 3 038 740 total index
hospital stays from January 2012 to September
2015: 1 357 620 for heart failure, 634 795 for
acute myocardial infarction, and 1 046 325 for
pneumonia. Baseline characteristics for all index
hospital stays are shown in eTable 1. Over the study
period, 840 114 hospital revisits within 30 days of
discharge (counting only the first revisit of any type
after discharge) occurred, including 265 055 treatand-discharge visits to an emergency department,
80 083 observation stays, and 599 664 inpatient
readmissions (counting only the first revisit for
each type of encounter). After counting all revisits
after the index hospital stays, we found 1 064 410
total hospital revisits, of which 303 194 were treatand-discharge visits to an emergency department,
84 169 were observation stays, and 677 047 were
readmissions (eTable 2).
The number of first hospital revisits per 100
patient discharges for medical conditions targeted
by the HRRP increased during the study (monthly
change 0.016 revisits per 100 patient discharges
(95% confidence interval 0.006 to 0.026); table 1).
This change was driven by an increase in treat-anddischarge visits to an emergency department (0.022

(0.014 to 0.029)) and observation stays (0.022
(0.019 to 0.024)), which were only partly offset by
reductions in inpatient readmissions (−0.013 (−0.023
to −0.002)).
These changes became more pronounced after
we counted all revisits per patient within 30 days
of discharge. The monthly change in total hospital
revisits per 100 patient discharges increased (0.023
(95% confidence interval 0.010 to 0.035)), due to
a rise in treat-and-discharge visits to an emergency
department (0.023 (0.015 to 0.032)) and observation
stays (0.022 (0.020 to 0.025)), while readmissions
decreased (−0.023 (–0.035 to −0.012)). Figure 1 shows
spline fitted trends of hospital revisits across all target
conditions, and eFigures 1-2 show trends by individual
target condition.
Patient subgroups (age, sex, and race) were also
evaluated, as shown in table 2. Counting all revisits per
patient, the monthly change in total hospital revisits
per 100 patient discharges did not differ significantly
among patients younger than 80 compared with
patients aged 80 and over. Trends in treat-anddischarge visits to an emergency department,
observation stays, and readmissions also did not
differ between these age groups. In addition, we saw
no significant difference in revisit trends among men
compared to women. The monthly change in total
hospital revisits and in treat-and-discharge visits to
an emergency department were also similar among
white patients compared with non-white patients.
However, increases in observation stays within 30 days
of discharge were more pronounced among non-white
patients than white patients (monthly change 0.029
stays per 100 patient discharges (95% confidence
interval 0.024 to 0.034) v 0.021 (0.018 to 0.024);
P=0.006 for difference).
Overall, we observed no significant changes in
mortality within 30 days of discharge across the three
targeted conditions (−0.0034 (95% confidence interval
−0.012 to 0.0054)) from 2012 to 2015. Post-discharge
mortality at 30 days did not change among patients
admitted to hospital for heart failure (0.00 (−0.011 to
0.010)), acute myocardial infarction (−0.006 (−0.015
to 0.002)), or pneumonia (−0.004 (−0.013 to 0.005);
fig 2 and eTable 3).

Table 1 | Risk standardized monthly change in hospital revisits, treat-and-discharge visits to an emergency department,
observation stays, and readmissions within 30 days of discharge for medical conditions targeted by the HRRP in the US
First revisit*
Any hospital revisit
Treat-and-discharge visit to emergency department
Observation stay
Readmission
All revisits†
Any hospital revisit
Treat-and-discharge visit to emergency department
Observation stay
Readmission

Monthly change in No of revisits per 100 patient discharges (95% CI)

+0.016 (0.006 to 0.026)
+0.022 (0.014 to 0.029)
+0.022 (0.019 to 0.024)
−0.013 (−0.023 to −0.002)
+0.023 (0.010 to 0.035)
+0.023 (0.015 to 0.032)
+0.022 (0.020 to 0.025)
−0.023 (−0.035 to −0.012)

Data based on Medicare fee-for-service patients aged 65 or over between 1 January 2012 and 1 October 2015. Target conditions include heart failure,
acute myocardial infarction, or pneumonia.
*Among patients with multiple hospital revisits within 30 days of discharge, only the first revisit for each type of encounter was counted.
†Among patients with multiple hospital revisits within 30 days of discharge, all visits for each type of encounter were counted.
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Fig 1 | Risk standardized hospital revisits, treat-and-discharge visits to an emergency department, observation stays, and readmissions within 30
days of discharge for medical conditions targeted by the HRRP in the US. Spline fitted trends of hospital revisits are shown for all target conditions
(heart failure, acute myocardial infarction, or pneumonia). Data based on Medicare fee-for-service patients aged 65 or over between 1 January 2012
and 1 October 2015. Yellow line=trends including only the first revisit for each type of encounter (eg, any hospital revisit, treat-and-discharge visit
to an emergency department, observation stay, or inpatient readmission); purple line=trends including all revisits for each type of encounter

Discussion
In this study of Medicare beneficiaries admitted to
hospital for heart failure, acute myocardial infarction,
and pneumonia in the US between 2012 and 2015,
we found an increase in total hospital revisits within
30 days of discharge despite a reduction in 30 day
readmissions. This increase was because of a rise in
treat-and-discharge visits to an emergency department
and observation stays within 30 days of discharge,
which on national level, exceeded the decline in
readmissions. Our finding of increased healthcare
use during this period was more pronounced after we
included all encounters within 30 days of discharge
from the index hospital stay—rather than simply
including the first revisit.
In the US, nationwide reductions in readmission
rates for medical conditions targeted by the HRRP have
been viewed as markers of improvements in quality of
care. Our findings suggest that this success could be
illusory because total hospital revisits after discharge
are, in fact, rising. If reductions in readmissions
were being driven by widespread improvements
in discharge planning, care transitions and postdischarge care after a hospital stay (as intended by
the HRRP), total hospital revisits within 30 days of
discharge would also be expected to decline. Instead,
much of the reduction in readmissions seems to reflect
intensified efforts to manage patients who return to
4

a hospital after discharge in observation units and
emergency departments, potentially because the 30
day readmission measure used to evaluate hospital
performance under the HRRP does not include these
types of post-discharge encounters. These observations
perhaps explain why previous studies have shown that
inpatient quality of care delivered to patients admitted
to hospital for heart failure or acute myocardial
infarction do not differ at hospitals with high versus
low readmission rates.11 12
The increase in use of observation stays and
emergency department visits (compared with inpatient
hospital stays) among patients who return after
discharge could be a good thing if it reflects that patients
are, on average, returning with lower severity illness
that can be safely managed in a non-admission setting.
These revisits could also be beneficial to patient care.
For instance, observation stays have been associated
with higher patient satisfaction than inpatient hospital
stays,13 although they can also result in higher out-ofpocket expenditures and more financial hardship for
patients than inpatient hospital stays.14 15
However, the increasing use of emergency
department visits for post-discharge care could be
problematic. Data have suggested that hospitals that
tend to manage patients in emergency departments
rather than admitting them for an inpatient stay
have higher rates of early death after discharge.16 We
doi: 10.1136/bmj.l4563 | BMJ 2019;366:l4563 | the bmj
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Table 2 | Risk standardized monthly change in hospital revisits, treat-and-discharge
visits to an emergency department (ED), observation stays, and readmissions within 30
days of discharge for medical conditions targeted by the HRRP in the US, categorized by
patient subgroups
Monthly change in No of revisits per 100 patient discharges (95% CI)
Patient characteristic
Age (<80 v ≥80 years)
First revisit†
Any hospital revisit
ED treat-and-discharge visit
Observation stay
Readmission
All revisits‡
Total hospital revisits
ED treat-and-discharge visit
Observation stay
Readmission
Sex (men v women)
First revisit†
Any hospital revisit
ED treat-and-discharge visit
Observation stay
Readmission
All revisits‡
Total hospital revisits
ED treat-and-discharge visit
Observation stay
Readmission
Race (white v non-white)
First revisit†
Any hospital revisit
ED treat-and-discharge visit
Observation stay
Readmission
All revisits‡
Total hospital revisits
ED treat-and-discharge visit
Observation stay
Readmission

P*

Comparator group 1

Comparator group 2

+0.016 (0.007 to 0.027)
+0.024 (0.016 to 0.032)
+0.023 (0.020 to 0.026)
−0.014 (−0.025 to −0.003)

+0.015 (0.004 to 0.026)
+0.019 (0.012 to 0.027)
+0.021 (0.018 to 0.023)
−0.012 (−0.023 to 0.00)

0.89
0.36
0.30
0.80

+0.030 (0.015 to 0.045)
+0.027 (0.017 to 0.037)
+0.024 (0.021 to 0.027)
−0.021 (−0.034 to −0.009)

+0.015 (0.012 to 0.028)
+0.020 (0.011 to 0.029)
+0.020 (0.017 to 0.024)
−0.026 (−0.038 to −0.014)

0.08
0.29
0.08
0.56

+0.016 (0.006 to 0.026)
+0.022 (0.015 to 0.029)
+0.023 (0.021 to 0.025)
−0.013 (−0.025 to −0.001)

+0.016 (0.005 to 0.027)
+0.021 (0.014 to 0.029)
+0.020 (0.017 to 0.024)
−0.012 (−0.023 to −0.002)

1.00
0.84
0.13
0.90

+0.024 (0.012 to 0.037)
+0.024 (0.015 to 0.034)
_+0.024 (0.022 to 0.027)
−0.024 (−0.037 to −0.012)

+0.021 (0.006 to 0.035)
+0.023 (0.013 to 0.032)
+0.021 (0.017 to 0.025)
−0.023 (−0.034 to −0.011)

0.75
0.88
0.20
0.91

+0.017 (0.008 to 0.027)
+0.022 (0.015 to 0.029)
+0.021 (0.018 to 0.023)
−0.011 (−0.022 to −0.001)

+0.009 (−0.005 to 0.023)
+0.020 (0.011 to 0.028)
+0.027 (0.023 to 0.031)
−0.021 (−0.035 to −0.007)

0.36
0.71
0.01
0.26

+0.023 (0.011 to 0.035)
+0.023 (0.014 to 0.033)
+0.021 (0.018 to 0.024)
−0.022 (−0.033 to −0.011)

+0.021 (0.001 to 0.043)
+0.024 (0.013 to 0.035)
+0.029 (0.024 to 0.034)
−0.031 (−0.048 to −0.014)

0.87
0.89
0.006
0.37

Data based on Medicare fee-for-service patients aged 65 or over between 1 January 2012 and 1 October 2015.
Target conditions include heart failure, acute myocardial infarction, or pneumonia.
*P value for difference in monthly change among subgroups.
†Among patients with multiple hospital revisits within 30 days of discharge, only the first revisit for each type of
encounter was counted.
‡Among patients with multiple hospital revisits within 30 days of discharge, all visits for each type of encounter
were counted.

observed no change in post-discharge mortality at 30
days for target conditions during the HRRP (from 2012
to 2015). However, several independent analyses
have found that the implementation of the HRRP was
associated with an increase in post-discharge mortality
at 30 days among patients admitted for heart failure
and pneumonia compared with pre-HRRP trends (pre2010), and that this increase was concentrated entirely
among patients not readmitted after discharge.6 1719
Whether intensified efforts to manage returning
patients in emergency departments and observation
units explain increases in mortality observed in the
years that preceded our study period is an important
area for further research, given that this potential
mechanism could explain increased mortality under
the HRRP.20-24

Policy implications
Our findings have important policy implications for
value based programs that use the 30 day readmission
the bmj | BMJ 2019;366:l4563 | doi: 10.1136/bmj.l4563

measure to evaluate hospital and provider care quality.
Firstly, focusing on 30 day readmissions while ignoring
other types of hospital revisits overestimates the
clinical and financial benefits of incentives to reduce
readmissions. Secondly, use of 30 day readmissions as
the sole quality metric could impede fair comparisons
of hospital performance, particularly given wide
variation in triage patterns in emergency departments
and the availability and use of observation units.25
Finally, given these limitations, the 30 day readmission
rate seems to be an inappropriate target for financial
incentives for hospitals (as used in the HRRP) or
outpatient practices (as being increasingly used in
pay-for-performance programs). Measuring all revisits
within 30 days of discharge (that is, a “30 day return
to hospital” metric) could instead provide a more
comprehensive, accurate, and fair assessment of
provider and hospital care quality.26
Several countries, including England, Germany, and
Denmark, have implemented national level policies
that aim to reduce readmissions, and others are
actively considering similar initiatives.27 In England,
incentives to reduce all cause readmissions were
announced in 2010,28 and from fiscal years 2011-12,
hospitals were no longer reimbursed for readmissions
within 30 days of discharge exceeding a locally set
threshold. However, the extent to which reductions in
readmissions in England are due to improved quality
of care during the index hospital stay, or instead, are
due to greater management and treatment of patients
who return after discharge in emergency departments
is unknown. This area is important for future study,
particularly given growing concern in the US that a
focus on reducing readmissions could have adversely
affected patients at the margin who would have
benefited from inpatient level care.

Strengths and limitations of this study
Our study had limitations. We did not examine
whether the increase in total hospital revisits, and
emergency department visits and observation stays
in particular, was associated with changes in patient
satisfaction, or changes in Medicare spending and
beneficiary out-of-pocket expenditures. We were also
unable to evaluate whether greater shifts in emergency
department and observation use occurred in the years
before our study, when the HRRP was announced in
2010, and if this affected patient experience, quality
of care, and mortality. This area remains important for
future research given ongoing discussions regarding
the potential unintended consequences of this
program.21-23 26 29-31
Conclusions
Although readmissions for target conditions decreased
from 2012 to 2015 in the US, total hospital revisits
within 30 days of discharge steadily increased over that
same period. This increase was due to a rise in treatand-discharge encounters in emergency departments
and observation stays, which on a national level,
exceeded the decline in readmissions over the same
5
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Data sharing: No additional data are available due to data use
agreement with the Centers for Medicare and Medicaid Services.
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Fig 2 | Risk standardized mortality within 30 days of discharge among Medicare
patients admitted to hospital for heart failure, acute myocardial infarction, or
pneumonia (medical conditions targeted by the HRRP in the US). Spline fitted trends
of mortality are shown, by target condition. Data based on Medicare fee-for-service
patients aged 65 or over between 1 January 2012 and 1 October 2015

period. Given that total hospital revisits are rising,
nationwide reductions in readmissions could reflect
intensified efforts to manage patients who return to
a hospital after discharge to emergency departments
and observation units rather than improvements in
discharge planning and care transitions during index
hospital stays, as intended by the HRRP. Future policy
efforts in the US could benefit from measuring total
hospital revisits within 30 days of discharge instead
of solely focusing on readmissions, to strengthen
incentives to improve quality of care and provide a
more comprehensive assessment of care quality and
healthcare use in the post-discharge period.
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